Carregant...
Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19
Hypercoagulability and thrombosis caused by coronavirus disease 2019 (COVID‐19) are related to the higher mortality rate. Because of limited data on the antiplatelet effect, we aimed to evaluate the impact of aspirin add‐on therapy on the outcome of the patients hospitalized due to severe COVID‐19....
Guardat en:
| Publicat a: | J Med Virol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8242852/ https://ncbi.nlm.nih.gov/pubmed/33913549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.27053 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|